Non-cosmetic dermatological uses of botulinum neurotoxin

被引:10
作者
Forbat, E. [1 ]
Ali, F. R. [2 ]
Al-Niaimi, F. [2 ]
机构
[1] King Edward VII Hosp, London, England
[2] St Thomas Hosp, Dermatol Surg & Laser Unit, St Johns Inst Dermatol, London, England
关键词
TOXIN TYPE-A; HAILEY-HAILEY-DISEASE; PRIMARY AXILLARY HYPERHIDROSIS; RESIDUAL LIMB HYPERHIDROSIS; CHRONIC ANAL-FISSURE; DOUBLE-BLIND; HIDRADENITIS SUPPURATIVA; PALMAR HYPERHIDROSIS; FOCAL HYPERHIDROSIS; CONTROLLED-TRIAL;
D O I
10.1111/jdv.13772
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Botulinum neurotoxin (BoNT) is renowned for its inhibitory effects on the neuromuscular junction. The evidence for its use in cosmetic dermatology and in non-dermatological indications is well established. We have systemically analysed the evidence for the non-cosmetic dermatological uses of BoNT. This review presents the many small studies showing promising results for the use of BoNT in a multitude of dermatological diseases, including (but not limited to) hyperhidrosis, Darier's disease, Hailey-Hailey disease, pompholyx and hidradenitis suppurativa. There is, however, the need for larger, double-blinded randomized control trials against established treatments to cement the evidence base underlying the use of BoNT in dermatology.
引用
收藏
页码:2023 / 2029
页数:7
相关论文
共 88 条
  • [1] Comparison of OnabotulinumtoxinA and RimabotulinumtoxinB for the Treatment of Axillary Hyperhidrosis
    An, Jee Soo
    Hyun Won, Chong
    Si Han, Ji
    Park, Hyun Sun
    Seo, Kyle K.
    [J]. DERMATOLOGIC SURGERY, 2015, 41 (08) : 960 - 967
  • [2] Aoki KR, 2003, HEADACHE, V43, pS9
  • [3] Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions
    Aoki, KR
    Guyer, B
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 : 21 - 29
  • [4] Botulinum toxin treatment for symptomatic Frey's syndrome
    Arad-Cohen, A
    Blitzer, A
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2000, 122 (02) : 237 - 240
  • [5] Letter: Aquagenic Keratoderma: Successful Treatment with Botulinum Toxin
    Bagazgoitia, Lorea
    Perez-Carmona, Lucia
    Salguero, Irene
    Harto, Antonio
    Jaen, Pedro
    [J]. DERMATOLOGIC SURGERY, 2010, 36 (03) : 434 - 436
  • [6] Clinical differences between botulinum neurotoxin type A and B
    Bentivoglio, Anna Rita
    Del Grande, Alessandra
    Petracca, Martina
    Ialongo, Tamara
    Ricciardi, Lucia
    [J]. TOXICON, 2015, 107 : 77 - 84
  • [7] Hailey-Hailey disease treatment with Botulinum toxin type A
    Bessa, Giancarlo Rezende
    Grazziotin, Thais Corsetti
    Manzoni, Ana Paula
    Weber, Magda Blessmann
    Bonamigo, Renan Rangel
    [J]. ANAIS BRASILEIROS DE DERMATOLOGIA, 2010, 85 (05) : 717 - 722
  • [8] Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin A inhibitors
    Boldt, Grant E.
    Kennedy, Jack P.
    Hixon, Mark S.
    McAllister, Laura A.
    Barbieri, Joseph T.
    Tzipori, Saul
    Janda, Kim D.
    [J]. JOURNAL OF COMBINATORIAL CHEMISTRY, 2006, 8 (04): : 513 - 521
  • [9] Botulinum neurotoxin to treat chronic anal fissure: results of a randomized 'Botox vs. Dysport' controlled trial
    Brisinda, G
    Albanese, A
    Cadeddu, F
    Bentivoglio, AR
    Mabisombi, A
    Marniga, G
    Maria, G
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (06) : 695 - 701
  • [10] Botulinum toxin type A: History and current cosmetic use in the upper face
    Carruthers, A
    [J]. DM DISEASE-A-MONTH, 2002, 48 (05): : 299 - 322